Jamie Clark
Stock Analyst at Rothschild & Co
(1.99)
# 3,036
Out of 5,163 analysts
9
Total ratings
57.14%
Success rate
3.66%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jamie Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Initiates: Buy | $311 | $235.46 | +32.08% | 1 | Sep 15, 2025 | |
| MEDP Medpace Holdings | Downgrades: Neutral | $342 → $474 | $450.41 | +5.24% | 1 | Sep 3, 2025 | |
| ICLR ICON Public Limited Company | Upgrades: Buy | $184 → $236 | $98.33 | +140.01% | 1 | Sep 3, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $188 → $182 | $155.46 | +17.07% | 3 | May 23, 2025 | |
| LH Labcorp Holdings | Initiates: Buy | $276 | $263.80 | +4.62% | 1 | Apr 2, 2025 | |
| DGX Quest Diagnostics | Initiates: Buy | $195 | $199.70 | -2.35% | 1 | Apr 2, 2025 | |
| IQV IQVIA Holdings | Initiates: Buy | $276 | $164.72 | +67.56% | 1 | Oct 14, 2024 |
West Pharmaceutical Services
Sep 15, 2025
Initiates: Buy
Price Target: $311
Current: $235.46
Upside: +32.08%
Medpace Holdings
Sep 3, 2025
Downgrades: Neutral
Price Target: $342 → $474
Current: $450.41
Upside: +5.24%
ICON Public Limited Company
Sep 3, 2025
Upgrades: Buy
Price Target: $184 → $236
Current: $98.33
Upside: +140.01%
Charles River Laboratories International
May 23, 2025
Upgrades: Buy
Price Target: $188 → $182
Current: $155.46
Upside: +17.07%
Labcorp Holdings
Apr 2, 2025
Initiates: Buy
Price Target: $276
Current: $263.80
Upside: +4.62%
Quest Diagnostics
Apr 2, 2025
Initiates: Buy
Price Target: $195
Current: $199.70
Upside: -2.35%
IQVIA Holdings
Oct 14, 2024
Initiates: Buy
Price Target: $276
Current: $164.72
Upside: +67.56%